About RheoDx

We provide a new way to measure the behavior of blood in motion. RHEO Dx can detect, with a sample of blood as small as a drop, minimum changes in rheological properties, that are an indicator of abnormalities in red blood cells morphology or rigidity. These abnormalities are associated with an enormous set of diseases and conditions, such as blood coagulation disorders , malignant homeopathies, malaria, hereditary anaemias, and any other disease related to blood cells rheology.

Company Highlights
Year Founded

2018

icon-altEmployees

3

Location (HQ)

ESP

Since Last Funding

5 years 5 months

icon-altTotal Investment Amt

$400K

Last Funding Round

Seed

Key Metrics

Senior Hires

NameLinkedin ProfilePositionDate Joined
John Doehttps://www.linkedin.com/in/johndoeCEOCEO
Jane Doehttps://www.linkedin.com/in/janedoeCTOCTO
John Smithhttps://www.linkedin.com/in/johnsmithCFOCFO
Jane Smithhttps://www.linkedin.com/in/janesmithCOOCOO
Get API access to complete private company database with growth metrics from 15 sources

Health Care

Medical Equipment Manufacturing

Life Science

Biopharma

Health Diagnostics

Medical Device